These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 12668698
1. Aldosterone blockade and heart failure. Jessup M. N Engl J Med; 2003 Apr 03; 348(14):1380-2. PubMed ID: 12668698 [No Abstract] [Full Text] [Related]
3. [Aldosterone receptor blockade after acute myocardial infarction with heart failure]. Bauersachs J, Ertl G. Med Klin (Munich); 2006 Jun 15; 101(6):458-66. PubMed ID: 16767569 [Abstract] [Full Text] [Related]
4. Pfizer launches Inspra for heart failure. Cardiovasc J S Afr; 2006 Jun 15; 17(4):220. PubMed ID: 17001435 [No Abstract] [Full Text] [Related]
5. [Selective aldosterone blocking in heart failure. Eplerenone reduces the risk after infarction]. MMW Fortschr Med; 2003 Oct 30; 145(44):42-3. PubMed ID: 14655506 [No Abstract] [Full Text] [Related]
6. Aldosterone blockade in patients with systolic left ventricular dysfunction. Pitt B. Circulation; 2003 Oct 14; 108(15):1790-4. PubMed ID: 14557343 [No Abstract] [Full Text] [Related]
7. [Aldosterone receptor antagonists in heart failure. Rightly brought back from retirement]. Kolloch R, Offers E. MMW Fortschr Med; 2003 Nov 20; 145(47):42-4, 47. PubMed ID: 14725033 [Abstract] [Full Text] [Related]
8. Management of heart failure and left ventricular systolic dysfunction following acute myocardial infarction. Conti CR. Clin Cardiol; 2005 Jan 20; 28(1):1-2. PubMed ID: 15704523 [No Abstract] [Full Text] [Related]
9. Should the aldosterone-receptor antagonist - eplerenone - be used after acute myocardial infarction with left ventricular dysfunction? Doggrell S. Expert Opin Pharmacother; 2003 Sep 20; 4(9):1605-7. PubMed ID: 12943490 [No Abstract] [Full Text] [Related]
11. Blocking aldosterone in heart failure. Shafiq MM, Miller AB. Ther Adv Cardiovasc Dis; 2009 Oct 02; 3(5):379-85. PubMed ID: 19661156 [Abstract] [Full Text] [Related]
12. MRAs in Patients With AMI Without Early Evidence of Heart Failure: Time for Reappraisal? Pitt B. J Am Coll Cardiol; 2016 Apr 26; 67(16):1928-30. PubMed ID: 27102507 [No Abstract] [Full Text] [Related]
14. [Misdiagnosed emergency: heart failure symptoms after infarct. Rapid aldosterone block can safe the tired heart]. MMW Fortschr Med; 2008 May 29; 150(22):48-9. PubMed ID: 18700263 [No Abstract] [Full Text] [Related]
15. Eplerenone in patients with left ventricular dysfunction. Aggarwal A. N Engl J Med; 2003 Jul 03; 349(1):88-9; author reply 88-9. PubMed ID: 12840098 [No Abstract] [Full Text] [Related]
16. Aldosterone antagonists: a new treatment option for patients with post-myocardial infarction heart failure. Ajani AE, Marwick TH, Krum H. Cardiovasc Revasc Med; 2006 Jul 03; 7(4):234-6. PubMed ID: 17174870 [Abstract] [Full Text] [Related]
17. Mineralocorticoid receptor antagonists for heart failure. Funder J. Expert Opin Pharmacother; 2011 Dec 03; 12(18):2767-9. PubMed ID: 22098225 [No Abstract] [Full Text] [Related]
18. Do diuretics and aldosterone receptor antagonists improve ventricular remodeling? Pitt B. J Card Fail; 2002 Dec 03; 8(6 Suppl):S491-3. PubMed ID: 12555163 [Abstract] [Full Text] [Related]
19. More hope for heart failure. Findings suggest expanded use of aldosterone-blockers. Aaronson K. Health News; 2003 May 03; 9(5):4. PubMed ID: 12739453 [No Abstract] [Full Text] [Related]
20. Eplerenone in patients with left ventricular dysfunction. Coca SG, Buller GK. N Engl J Med; 2003 Jul 03; 349(1):88-9; author reply 88-9. PubMed ID: 12846223 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]